BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 28167531)

  • 1. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
    Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
    J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.
    Chen CX; Cho DS; Wang Q; Lai F; Carter KC; Nishikura K
    RNA; 2000 May; 6(5):755-67. PubMed ID: 10836796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS.
    Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA
    J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
    Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
    Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zebrafish Adar2 Edits the Q/R site of AMPA receptor Subunit gria2α transcript to ensure normal development of nervous system and cranial neural crest cells.
    Li IC; Chen YC; Wang YY; Tzeng BW; Ou CW; Lau YY; Wu KM; Chan TM; Lin WH; Hwang SP; Chow WY
    PLoS One; 2014; 9(5):e97133. PubMed ID: 24818983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons.
    Whitney NP; Peng H; Erdmann NB; Tian C; Monaghan DT; Zheng JC
    FASEB J; 2008 Aug; 22(8):2888-900. PubMed ID: 18403631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
    Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
    Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas.
    Maas S; Patt S; Schrey M; Rich A
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14687-92. PubMed ID: 11717408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
    Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S
    Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low editing efficiency of GluR2 mRNA is associated with a low relative abundance of ADAR2 mRNA in white matter of normal human brain.
    Kawahara Y; Ito K; Sun H; Kanazawa I; Kwak S
    Eur J Neurosci; 2003 Jul; 18(1):23-33. PubMed ID: 12859334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA editing enzyme ADAR2 is a mediator of neuropathic pain after peripheral nerve injury.
    Uchida H; Matsumura S; Okada S; Suzuki T; Minami T; Ito S
    FASEB J; 2017 May; 31(5):1847-1855. PubMed ID: 28126736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of the RNA-editing enzyme ADAR2 for normal physiology in mice.
    Horsch M; Seeburg PH; Adler T; Aguilar-Pimentel JA; Becker L; Calzada-Wack J; Garrett L; Götz A; Hans W; Higuchi M; Hölter SM; Naton B; Prehn C; Puk O; Rácz I; Rathkolb B; Rozman J; Schrewe A; Adamski J; Busch DH; Esposito I; Graw J; Ivandic B; Klingenspor M; Klopstock T; Mempel M; Ollert M; Schulz H; Wolf E; Wurst W; Zimmer A; Gailus-Durner V; Fuchs H; de Angelis MH; Beckers J
    J Biol Chem; 2011 May; 286(21):18614-22. PubMed ID: 21467037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR2-mediated Q/R editing of GluK2 regulates kainate receptor upscaling in response to suppression of synaptic activity.
    Gurung S; Evans AJ; Wilkinson KA; Henley JM
    J Cell Sci; 2018 Dec; 131(24):. PubMed ID: 30559217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.
    Liu Y; Samuel CE
    J Biol Chem; 1999 Feb; 274(8):5070-7. PubMed ID: 9988754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site.
    Jaikaran DC; Collins CH; MacMillan AM
    J Biol Chem; 2002 Oct; 277(40):37624-9. PubMed ID: 12163487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAR2 A-->I editing: site selectivity and editing efficiency are separate events.
    Källman AM; Sahlin M; Ohman M
    Nucleic Acids Res; 2003 Aug; 31(16):4874-81. PubMed ID: 12907730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons.
    Bonini D; Filippini A; La Via L; Fiorentini C; Fumagalli F; Colombi M; Barbon A
    RNA Biol; 2015; 12(1):43-53. PubMed ID: 25625181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase.
    Maas S; Melcher T; Herb A; Seeburg PH; Keller W; Krause S; Higuchi M; O'Connell MA
    J Biol Chem; 1996 May; 271(21):12221-6. PubMed ID: 8647818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editing of AMPA and serotonin 2C receptors in individual central neurons, controlling wakefulness.
    Sergeeva OA; Amberger BT; Haas HL
    Cell Mol Neurobiol; 2007 Aug; 27(5):669-80. PubMed ID: 17554622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of conditioned fear is followed by region-specific changes in RNA editing of glutamate receptors.
    Brande-Eilat N; Golumbic YN; Zaidan H; Gaisler-Salomon I
    Stress; 2015; 18(3):309-18. PubMed ID: 26383032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.